AR038340A1 - Procedimiento para la preparacion de perindopril de alta pureza e intermediarios utiles en la sintesis - Google Patents

Procedimiento para la preparacion de perindopril de alta pureza e intermediarios utiles en la sintesis

Info

Publication number
AR038340A1
AR038340A1 ARP030100263A ARP030100263A AR038340A1 AR 038340 A1 AR038340 A1 AR 038340A1 AR P030100263 A ARP030100263 A AR P030100263A AR P030100263 A ARP030100263 A AR P030100263A AR 038340 A1 AR038340 A1 AR 038340A1
Authority
AR
Argentina
Prior art keywords
formula
compound
preparation
lower alkyl
perindoprile
Prior art date
Application number
ARP030100263A
Other languages
English (en)
Inventor
Gyula Simig
Tibor Mezei
Marta Procs-Makkay
Attila Mandi
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR038340A1 publication Critical patent/AR038340A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere al ácido 1{-2(S)-[1(S)-(etoxicarbonil)butilamino]propionil}-(3aS,7aS)octahidroindol-2(S)-carboxílico de fórmula (1) y a la sal de t-butilamina de fórmula (2) del mismo, libre de contaminaciones que pueden derivar de diciclohexilcarbodiimida, y a un procedimiento para la preparación del mismo. También se refiere a nuevos intermediarios de la fórmula general (3) (donde R representa alquilo inferior o aril-alquilo inferior). El compuesto de fórmula (1) -perindopril- es conocido como inhibidores de la ECA. Reivindicación 3: Procedimiento de acuerdo con la reivindicación 1 ó 2, para la preparación del compuesto de fórmula (1) y la sal de t-butilamina de la fórmula (2) libre de contaminaciones que pueden derivar de diciclohexilcarbodiimida, en particular libre de compuestos de la fórmula (4) y (5), que consiste en someter a reacción el compuesto de fórmula (6) con un derivado de ácido carbónico; activar el compuesto de la fórmula general (3) obtenido de esta manera (donde R representa alquilo inferior o aril-alquilo inferior) con cloruro de tionilo; someter a reacción el compuesto activado obtenido de esta manera con un compuesto de la fórmula (7); y, si se desea, cometer a reacción el compuesto de fórmula (1) obtenido de esta manera con t-butilamina.
ARP030100263A 2002-01-30 2003-01-30 Procedimiento para la preparacion de perindopril de alta pureza e intermediarios utiles en la sintesis AR038340A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02290206A EP1333026B1 (en) 2002-01-30 2002-01-30 Process for the preparation of high purity perindopril and intermediates useful in the synthesis

Publications (1)

Publication Number Publication Date
AR038340A1 true AR038340A1 (es) 2005-01-12

Family

ID=8185713

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100263A AR038340A1 (es) 2002-01-30 2003-01-30 Procedimiento para la preparacion de perindopril de alta pureza e intermediarios utiles en la sintesis

Country Status (36)

Country Link
US (2) US7326794B2 (es)
EP (1) EP1333026B1 (es)
JP (1) JP4171423B2 (es)
KR (1) KR100673701B1 (es)
CN (1) CN1300111C (es)
AP (1) AP1741A (es)
AR (1) AR038340A1 (es)
AT (1) ATE365714T1 (es)
AU (1) AU2003206055B2 (es)
BG (1) BG66126B1 (es)
BR (2) BRPI0307293B1 (es)
CA (1) CA2474003C (es)
CY (1) CY1106721T1 (es)
CZ (1) CZ305892B6 (es)
DE (1) DE60220877T2 (es)
DK (1) DK1333026T3 (es)
EA (1) EA009277B1 (es)
EE (1) EE05428B1 (es)
ES (1) ES2289060T3 (es)
GE (1) GEP20063899B (es)
HK (1) HK1076101A1 (es)
HR (1) HRP20040781B8 (es)
HU (1) HU227591B1 (es)
ME (1) ME00444B (es)
MX (1) MXPA04007444A (es)
NO (1) NO330223B1 (es)
NZ (1) NZ534168A (es)
OA (1) OA12759A (es)
PL (1) PL212354B1 (es)
PT (1) PT1333026E (es)
RS (1) RS52465B (es)
SI (1) SI1333026T1 (es)
SK (1) SK287866B6 (es)
UA (1) UA77756C2 (es)
WO (1) WO2003064388A2 (es)
ZA (1) ZA200405548B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60330603D1 (de) * 2003-10-21 2010-01-28 Servier Lab Verfahren zur herstellung kristallinem perindopril erbumin
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
WO2005094793A1 (en) * 2004-03-29 2005-10-13 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for preparing a solid pharmaceutical composition
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
ES2314583T4 (es) 2005-01-06 2009-05-18 Ipca Laboratories Limited Proceso para sintesis de los derivados del acido (2s,3as,7as)-1-(s)-alanil-octahidro-1h-indol-2-carboxilico y su utilizacion en la sintesis de perindropil.
US7710739B2 (en) 2005-04-28 2010-05-04 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and display device
WO2006137082A1 (en) * 2005-06-23 2006-12-28 Ramesh Babu Potluri Process for industrially viable preparation of perindopril erbumine
US20070032661A1 (en) * 2005-08-03 2007-02-08 Glenmark Pharmaceuticals Limited Process for the preparation of intermediates of perindopril
UA92613C2 (ru) * 2005-08-12 2010-11-25 Лек Фармасьютиклз Д.Д. Способ получения кристаллической формы d эрбумина периндоприла
EP1792896A1 (en) * 2005-12-01 2007-06-06 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of perindopril and salts thereof
UA98767C2 (uk) * 2006-05-12 2012-06-25 Егіш Дьйодьсердьяр Нільваношан Мюкьодо Ресвеньтаршашаг Фармацевтичні проміжні сполуки в синтезі інгібіторів ацетилхолінестерази (асе)
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144769C (da) 1979-12-06 1982-12-13 Voelund Vaskerimaskiner Tromlevaskemaskine med varmeveksler
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4565819A (en) * 1979-12-07 1986-01-21 Adir Substituted imino diacids, their preparation and pharmaceutical compositions which contain them
IN156096B (es) 1981-03-19 1985-05-11 Usv Pharma Corp
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
SI9600169A (en) 1996-05-22 1997-12-31 Krka Tovarna Zdravil Process for preparation of compounds with ace inhibitory effect
FR2807431B1 (fr) 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
AR036187A1 (es) 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
FR2827860B1 (fr) 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril

Also Published As

Publication number Publication date
HRP20040781A8 (en) 2009-01-31
NZ534168A (en) 2006-11-30
HRP20040781A2 (en) 2004-12-31
US20050119492A1 (en) 2005-06-02
US7326794B2 (en) 2008-02-05
HRP20040781B8 (en) 2009-01-31
PL212354B1 (pl) 2012-09-28
GEP20063899B (en) 2006-08-10
SK3292004A3 (en) 2004-12-01
CZ305892B6 (cs) 2016-04-27
EA200400929A1 (ru) 2005-06-30
NO20043472L (no) 2004-08-20
EE200400107A (et) 2004-10-15
BG108858A (en) 2005-05-31
US20070197821A1 (en) 2007-08-23
AP2004003091A0 (en) 2004-09-30
HK1076101A1 (en) 2006-01-06
DE60220877T2 (de) 2008-04-10
BRPI0307293B1 (pt) 2018-03-06
DE60220877D1 (de) 2007-08-09
KR20040078680A (ko) 2004-09-10
HU227591B1 (hu) 2011-09-28
ATE365714T1 (de) 2007-07-15
CA2474003C (en) 2009-06-02
SI1333026T1 (sl) 2007-10-31
CZ2004906A3 (cs) 2004-12-15
WO2003064388A2 (en) 2003-08-07
OA12759A (en) 2006-07-04
AP1741A (en) 2007-05-16
CN1300111C (zh) 2007-02-14
US7279595B2 (en) 2007-10-09
HU0300231D0 (en) 2003-03-28
EE05428B1 (et) 2011-06-15
HRP20040781B1 (en) 2008-12-31
KR100673701B1 (ko) 2007-01-24
EP1333026A1 (en) 2003-08-06
JP4171423B2 (ja) 2008-10-22
UA77756C2 (uk) 2007-01-15
EA009277B1 (ru) 2007-12-28
AU2003206055B2 (en) 2008-07-17
PT1333026E (pt) 2007-09-17
ZA200405548B (en) 2006-09-27
EP1333026B1 (en) 2007-06-27
JP2005521667A (ja) 2005-07-21
NO330223B1 (no) 2011-03-07
CN1622936A (zh) 2005-06-01
RS66704A (en) 2007-02-05
ME00444B (me) 2011-10-10
SK287866B6 (sk) 2012-02-03
ES2289060T3 (es) 2008-02-01
RS52465B (en) 2013-02-28
HUP0300231A2 (hu) 2003-08-28
HUP0300231A3 (en) 2004-04-28
WO2003064388A3 (en) 2004-02-05
BR0307293A (pt) 2004-12-21
CA2474003A1 (en) 2003-08-07
CY1106721T1 (el) 2012-05-23
BG66126B1 (bg) 2011-06-30
MXPA04007444A (es) 2005-06-17
PL358514A1 (en) 2003-07-28
DK1333026T3 (da) 2007-10-22

Similar Documents

Publication Publication Date Title
AR038340A1 (es) Procedimiento para la preparacion de perindopril de alta pureza e intermediarios utiles en la sintesis
US4156786A (en) Amino acid derivatives
GB1591229A (en) Substituted acyl derivatives of amino acids
Moynihan et al. Preparation of some novel S-nitroso compounds as potential slow-release agents of nitric oxide in vivo
GEP20105036B (en) Perindopril
MY109846A (en) Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them
AU733420B2 (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
UY27842A1 (es) Fluorobenzamidas
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
JPH02502537A (ja) 哺乳動物コラゲナーゼの合成阻止剤
AR036187A1 (es) Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
Sheehan et al. Peptide syntheses using energy-rich phosphorylated amino acid derivatives
Pearson et al. Photoswitch inhibitors of α-chymotrypsin—increased substitution and peptidic character in peptidomimetic boronate esters
CO5160245A1 (es) Compuestos organicos inhibidores de las proteinasas de cisteina, en particular inhibidores de catepsina k de arilaminoalquilamida, y su uso farmaceutico para el tratamiento o la profilaxis de enfermedades o condiciones medicas en donde este implicada
IT1201443B (it) Intermedi per la sintesi di acidi carbossilici
AR042295A1 (es) Sales fumarato cristalinas de furo [ 2,3- c ] piridinilcarboxamida sustituida con 1- azabiciclo [ 2. 2. 2 ] octilo y composiciones y preparaciones de las mismas
HK1052001A1 (en) A process for the preparation of alpha-chloroketones
BR0314714A (pt) Compostos para o tratamento da doença de alzheimer
AU2003220441A8 (en) Dipeptidic growth hormone secretagogues
PE20030758A1 (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
Rozengart Substrate–inhibitor analysis of cholinesterase from hemolymph of the Pacific gastropod mollusc Neptunea eulimata
Kotzur et al. Competition between cleavage and decarboxylation in photolysis of α-carboxy-2-nitrobenzyl protected cysteine derivatives
AU714155B2 (en) Process for synthesizing carbapenem side chain intermediates
EP1445262A4 (en) PEPTIDE DERIVATIVE, PHARMACEUTICALLY SALT SUBSTANTIAL, METHOD FOR ITS PREPARATION AND ITS USE

Legal Events

Date Code Title Description
FA Abandonment or withdrawal